|
Vida Ventures
|
|
Vida Ventures is a bicoastal life sciences investment firm, founded in 2017 by a group of scientists, physicians, entrepreneurs, and investors who are passionate about building and funding breakthroughs in biomedicine. The firm's inaugural fund was raised in November 2017 and has $295 million in assets under management. Vida Ventures’ mission is to "bring science to life by advancing transformative biomedical innovations that have the potential to make a meaningful impact on the lives of patients". Vida Ventures is headquartered in Boston, Massachusetts. Portfolio Currently, Vida Ventures holds equity stakes in the following life sciences companies: *A2 Biotherapeutics *Allogene Therapeutics *Homology Medicines *Kronos Bio *Pionyr Immunotherapeutics *Praxis Precision Medicines *Sutro Biopharma Business history * In August 2017, it was reported that Vida Ventures has participated in a $83.5 million Series B financing round for Homology Medicines. * In December 2017, it was announced that Vida Ventures participated in a $62 million Series B financing round for Pionyr Therapeutics. * In March 2018, Homology Medicines, one of the companies Vida Ventures has invested in, began trading on the Nasdaq Global Select Market under the ticker "FIXX". Homology Medicines has raised $165 million in its initial public offering. * In April 2018, it was announced that Vida Ventures participated in a $300 million Series A financing round for Allogene Therapeutics. * In May 2018, it was announced that Vida Ventures participated in a $18 million seed financing round for Kronos Bio. * In July 2018, it was announced that Vida Ventures participated in a $85.4 Series E financing round for Sutro Biopharma. 
|
| < Prev | Next > |
|---|
Main Menu
| Home |
| Articles |
| Search |
| Submit Article |
| Contact Us |
| Donate to Wikibin |
